Toxicologie > Valeurs de référence > Autres valeurs des organismes reconnus
Dernière mise à jour le 29/03/2024| Cible | Voie d'exposition | Type d'effet | Type d'exposition | Nom de valeur | Valeur | Source | Commentaire | Effet critique retenu | Etat du statut | Durée d'exposition | Milieu | Source d'exposition | Facteur | Contexte de gestion | Age dependent adjustments factors | ADAF - Tranche d'âge | ADAF - Valeur | ADAF - URL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Population générale | Inhalation | A seuil | Chronique | RfC | 0,009 mg.m-3 | US EPA (2004) | Nasal inflammation | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | REL | 0,8 µg.m-3 | OEHHA (2003) | Decreased sperm count/ejaculate, decreased percentage of viable and motile sperm, increased semen pH, and increased proportion of sperm with specific morphological abnormalities in human males | Final | Air ambiant | |||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,0006 (µg.m-3)-1 | US EPA (2004) | 95% upper bound | Nasal cavity (includes adenoma, adenocarcinoma, papillary adenoma, squamous cell carcinoma, and or/papilloma), hemangiosarcomas, mesotheliomas | Final | Air ambiant | ||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,0003 (µg.m-3)-1 | US EPA (2004) | central tendency estimate | Nasal cavity (includes adenoma, adenocarcinoma, papillary adenoma, squamous cell carcinoma, and or/papilloma), hemangiosarcomas, mesotheliomas | Final | Air ambiant | ||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,000071 (µg.m-3)-1 | OEHHA (1985) | rat nasal tumor incidence ( | Final | Air ambiant | |||||||||
| Population générale | Orale | A seuil | Chronique | RfD | 0,009 mg.kg-1.j-1 | US EPA (2004) | Testicular atrophy, liver peliosis, and adrenal cortical degeneration | Final | Eau | |||||||||
| Population générale | Orale | Sans seuil | Chronique | Oral Slope Factor | 2 (mg.kg-1.j-1)-1 | US EPA (2004) | 95% upper bound | Forestomach tumors, hemangiosarcomas, thyroid follicular cell adenomas or carcinomas | Final | Eau | ||||||||
| Population générale | Orale | Sans seuil | Chronique | Oral Slope Factor | 1 (mg.kg-1.j-1)-1 | US EPA (2004) | central tendency estimate | Forestomach tumors, hemangiosarcomas, thyroid follicular cell adenomas or carcinomas | Final | Eau |